Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ, Marshall MS. Yip-Schneider MT, et al. Among authors: sweeney cj. Int J Oncol. 1999 Aug;15(2):271-9. doi: 10.3892/ijo.15.2.271. Int J Oncol. 1999. PMID: 10402237
Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate.
Hahn NM, Reckova M, Cheng L, Baldridge LA, Cummings OW, Sweeney CJ. Hahn NM, et al. Among authors: sweeney cj. J Clin Oncol. 2009 Jan 20;27(3):460-3. doi: 10.1200/JCO.2008.19.9380. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064958 No abstract available.
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
Sweeney CJ, Roth BJ, Kabbinavar FF, Vaughn DJ, Arning M, Curiel RE, Obasaju CK, Wang Y, Nicol SJ, Kaufman DS. Sweeney CJ, et al. J Clin Oncol. 2006 Jul 20;24(21):3451-7. doi: 10.1200/JCO.2005.03.6699. J Clin Oncol. 2006. PMID: 16849761 Clinical Trial.
Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.
Li J, Juliar B, Yiannoutsos C, Ansari R, Fox E, Fisch MJ, Einhorn LH, Sweeney CJ. Li J, et al. Among authors: sweeney cj. J Clin Oncol. 2005 Feb 20;23(6):1185-91. doi: 10.1200/JCO.2005.05.089. J Clin Oncol. 2005. PMID: 15718315 Clinical Trial.
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species.
Shanmugam R, Kusumanchi P, Appaiah H, Cheng L, Crooks P, Neelakantan S, Peat T, Klaunig J, Matthews W, Nakshatri H, Sweeney CJ. Shanmugam R, et al. Among authors: sweeney cj. Int J Cancer. 2011 May 15;128(10):2481-94. doi: 10.1002/ijc.25587. Int J Cancer. 2011. PMID: 20669221 Free PMC article.
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
Yip-Schneider MT, Wu H, Ralstin M, Yiannoutsos C, Crooks PA, Neelakantan S, Noble S, Nakshatri H, Sweeney CJ, Schmidt CM. Yip-Schneider MT, et al. Among authors: sweeney cj. Mol Cancer Ther. 2007 Jun;6(6):1736-44. doi: 10.1158/1535-7163.MCT-06-0794. Epub 2007 May 31. Mol Cancer Ther. 2007. PMID: 17541034
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
Shanmugam R, Jayaprakasan V, Gokmen-Polar Y, Kelich S, Miller KD, Yip-Schneider M, Cheng L, Bhat-Nakshatri P, Sledge GW Jr, Nakshatri H, Zheng QH, Miller MA, DeGrado T, Hutchins GD, Sweeney CJ. Shanmugam R, et al. Among authors: sweeney cj. Prostate. 2006 Oct 1;66(14):1498-511. doi: 10.1002/pros.20482. Prostate. 2006. PMID: 16921510
Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease.
Hahn NM, Sweeney CJ. Hahn NM, et al. Among authors: sweeney cj. Urol Oncol. 2005 Jul-Aug;23(4):293-302. doi: 10.1016/j.urolonc.2005.05.008. Urol Oncol. 2005. PMID: 16018947 Review.
Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ. Sweeney CJ. Am J Clin Oncol. 2003 Aug;26(4):S122-5. doi: 10.1097/01.COC.0000074150.99253.26. Am J Clin Oncol. 2003. PMID: 12902869 Review.
Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma.
Brandli DW, Ulbright TM, Foster RS, Cummings OW, Zhang S, Sweeney CJ, Eble JN, Cheng L. Brandli DW, et al. Among authors: sweeney cj. Cancer Res. 2003 Sep 15;63(18):6063-8. Cancer Res. 2003. PMID: 14522936
222 results
Jump to page